| Identification | Back Directory | [Name]
(+)-8-(2-Hydroxy-3-methyl-3-butenyl)-7-methoxy-2H-1-benzopyran-2-one | [CAS]
1221-43-8 | [Synonyms]
(+)-Auraptenol
(S)-Auraptenol
8-(2-Hydroxy-3-methyl-3-butenyl)-7-methoxycoumarin
(+)-8-(2-Hydroxy-3-methyl-3-butenyl)-7-methoxy-2H-1-benzopyran-2-one
2H-1-Benzopyran-2-one,8-[(2S)-2-hydroxy-3-methyl-3-buten-1-yl]-7-methoxy- | [Molecular Formula]
C15H16O4 | [MDL Number]
MFCD20275009 | [MOL File]
1221-43-8.mol | [Molecular Weight]
260.29 |
| Hazard Information | Back Directory | [Description]
Auraptenol possesses robust antidepressant-like efficacy in mice.
Auraptenol attenuates vincristine-induced mechanical hyperalgesia through serotonin 5-HT1A receptors, it has potential to be a novel analgesic for the management of neuropathic pain.
3. Auraptenol shows high inhibitory activities against larval settlement of Balanus albicostatus with EC50values of 3.38 ug m/L. | [target]
5-HT Receptor |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|